Introduction: Hemophilia A (HA) therapy poses a significant healthcare burden. In recent years, emicizumab has been approved for prophylaxis. The current study explores the impact of transitioning to emicizumab on emergency department (ED) visits and hospitalizations in pediatric and adult HA patients.
View Article and Find Full Text PDFDisabil Rehabil Assist Technol
January 2025
The purpose of this study was to evaluate the effectiveness of custom seating and mobility services provided an international service learning (ISL) model on the occupational performance of individuals with disabilities in Guatemala. A one-group prospective pretest-posttest design was implemented using the standardized Wheelchair Outcome Measure (WhOM - Spanish) administered on the day of wheelchair fitting, and at 3- and 6-month intervals after receiving seating and mobility services. A two-tailed -test demonstrated a statistically significant ( < 0.
View Article and Find Full Text PDFJ Pediatr Hematol Oncol
August 2024
Background: Immune thrombotic thrombocytopenic purpura (iTTP) in children is a rare, severe thrombotic microangiopathy. This condition is characterized by microangiopathic hemolytic anemia, severe thrombocytopenia, and organ ischemia due to reduced activity of the von Willebrand factor-cleaving protease ADAMTS13.
Methods: A retrospective case series evaluating data collected from the medical files of 4 children diagnosed with iTTP.